Q1 2026 Psychedelic Drug Development Pipeline: Bullseye Charts By Watertime - February 19, 2026 8 Q1 2026 BULLSEYE CHARTS This resource is supported by Learn More UBC partners with biopharma to modernize evidence… Source RELATED ARTICLESMORE FROM AUTHOR Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy
